| dc.creator |
AFŞAR, Barış |
|
| dc.creator |
Afsar, Rengin Elsurer |
|
| dc.date |
2023-08-01T00:00:00Z |
|
| dc.date.accessioned |
2025-02-25T10:41:55Z |
|
| dc.date.available |
2025-02-25T10:41:55Z |
|
| dc.identifier |
f7b86cc4-fdd9-4f31-a0b4-9f92f9f2d82e |
|
| dc.identifier |
10.1007/s10522-023-10031-4 |
|
| dc.identifier |
https://avesis.sdu.edu.tr/publication/details/f7b86cc4-fdd9-4f31-a0b4-9f92f9f2d82e/oai |
|
| dc.identifier.uri |
http://acikerisim.sdu.edu.tr/xmlui/handle/123456789/101972 |
|
| dc.description |
Essential or primary hypertension is a wordwide health problem. Elevated blood pressure (BP) is closely associated not only with increased chronological aging but also with biological aging. There are various common pathways that play a role in cellular aging and BP regulation. These include but not limited to inflammation, oxidative stress, mitochondrial dysfunction, air pollution, decreased klotho activity increased renin angiotensin system activation, gut dysbiosis etc. It has already been shown that some anti-hypertensive drugs have anti-senescent actions and some senolytic drugs have BP lowering effects. In this review, we have summarized the common mechanisms underlying cellular senescence and HT and their relationships. We further reviewed the effect of various antihypertensive medications on cellular senescence and suggest further issues to be studied. |
|
| dc.language |
eng |
|
| dc.rights |
info:eu-repo/semantics/closedAccess |
|
| dc.title |
Hypertension and cellular senescence |
|
| dc.type |
info:eu-repo/semantics/article |
|